Loading
Latest filing published 28 Oct 2026 for Impedimed Limited.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christine Emmanuel-Donnelly is a declared insider at 2 companies; the most frequent names are Impedimed Limited and IPD. We count 4 filings; the first trade dates from 2 June 2026 and the latest from 27 October 2026.
On the market, this insider has only ever bought: 4 purchases. No amount is published for 4 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 28 October 2026 came the latest disclosure, an open-market purchase in Impedimed Limited. The median gap between a trade and its publication by ASX is 1 day. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations